This well-conducted review concluded that there was insufficient evidence to support the use of colour vision testing alone, or in combination with retinal photography, as a method for screening for retinopathy in patients with diabetes. Given the paucity of good quality evidence, the authors' conclusion seems appropriate and reliable.
Study selection
Diagnostic cohort and case-control studies (with at least 20 participants of any age with type 1 or type 2 diabetes, with either at least five patients with evidence of retinopathy, or all patients with diabetes) that compared any test of colour vision with a reference standard (fundus examination by fluorescein angiography, digital retinal photography, biomicroscopy or ophthalmoscopy) were eligible for inclusion. Sufficient data to construct 2x2 tables of test performance had to be reported to be included in the analyses. Studies of attitudes or preferences of patients with diabetes in relation to colour vision testing and 'phase I' studies comparing the range of test results in patients with and without retinopathy, or across stages of retinopathy, were also included.
Where reported, the mean age of participants ranged from 14 to 57.7 years, the proportion males ranged from 37 to 62%, and the proportion of participants with insulin dependent diabetes from 0% to 100%.
Two reviewers independently selected studies for retrieval. One reviewer screened full papers, with the decision checked by a second reviewer. Disagreements were resolved by consensus.
Assessment of study quality
One reviewer assessed study quality using the 14-item QUADAS (Quality Assessment of Diagnostic Accuracy Studies) tool; the results were checked by a second reviewer.
Data extraction
Data to construct 2×2 tables of test performance were extracted by one reviewer, from which sensitivity, specificity and likelihood ratios with 95% confidence intervals (CIs) were calculated. Data extraction was checked by a second reviewer.
